0000899243-19-024071.txt : 20190923
0000899243-19-024071.hdr.sgml : 20190923
20190923200018
ACCESSION NUMBER: 0000899243-19-024071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190919
FILED AS OF DATE: 20190923
DATE AS OF CHANGE: 20190923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tompkins Tamara
CENTRAL INDEX KEY: 0001501910
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38470
FILM NUMBER: 191109023
MAIL ADDRESS:
STREET 1: C/O AMYRIS, INC.
STREET 2: 5885 HOLLIS ST., SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unity Biotechnology, Inc.
CENTRAL INDEX KEY: 0001463361
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264726035
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3280 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: (415) 328-5504
MAIL ADDRESS:
STREET 1: 3280 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Cenexys, Inc.
DATE OF NAME CHANGE: 20130703
FORMER COMPANY:
FORMER CONFORMED NAME: Forge Inc
DATE OF NAME CHANGE: 20090504
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-19
0
0001463361
Unity Biotechnology, Inc.
UBX
0001501910
Tompkins Tamara
C/O UNITY BIOTECHNOLOGY, INC
3280 BAYSHORE BOULEVARD
BRISBANE
CA
94005
0
1
0
0
See Remarks
Common Stock, $0.0001 par value
21075
D
Stock Option (Right to Buy)
3.40
2019-09-19
4
A
0
19068
0.00
A
2019-09-19
2027-07-26
Common Stock
19068
19068
D
Includes Restricted Stock Units which vest over time measured from the grant date.
On July 26, 2017, Reporting Person was granted an option exercisable for 76,271 shares. Twenty-five percent (25%) of the shares was subject to vesting pursuant to the achievement of a clinical development milestone; in this case proof of concept that treatment with a senolytic drug meaningfully ameliorates a human disease. On September 19, 2019, Issuer's Board of Directors determined that such milestone was achieved.
Corporate Secretary and General Counsel
/s/ Tamara L. Tompkins
2019-09-23